Management of acute lymphoblastic leukemia in older patients

Seminars in Hematology
Richard A Larson

Abstract

Although the median age for adults with acute lymphoblastic leukemia (ALL) is older than 60 years, relatively few of these patients have been enrolled on prospective clinical trials. The presence of coexisting medical disorders and unfavorable cytogenetic and biologic disease characteristics within this population presents considerable challenges for successful treatment using conventional chemotherapy programs. Selected patients have achieved remission and long-term survival following intensive chemotherapy. Philadelphia (Ph) chromosome (BCR/ABL)-positive ALL is particularly common among older patients. The availability of specific tyrosine kinase inhibitors is changing the prognosis for this challenging subset.

References

May 1, 1994·Leukemia & Lymphoma·P R TaylorS J Proctor
Mar 18, 1999·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·K A GelmonL D Mayer
Feb 2, 2000·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·H M KantarjianE J Freireich
Mar 22, 2001·Hematology/oncology Clinics of North America·J P Radich
May 9, 2001·American Journal of Hematology·X ThomasD Fiere
Mar 6, 2003·Best Practice & Research. Clinical Haematology·Deborah A ThomasHagop M Kantarjian
Mar 29, 2003·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Joy H LewisJosé J Escarce
Apr 15, 2003·The Hematology Journal : the Official Journal of the European Haematology Association·Massimo OffidaniPietro Leoni
Apr 15, 2003·Bone Marrow Transplantation·I Avivi, A H Goldstone
Sep 27, 2003·Toxicology·Peter Crome
Dec 10, 2003·Mayo Clinic Proceedings·Rubin Bressler, Joseph J Bahl
Mar 11, 2004·Blood Reviews·Krzysztof MrózekClara D Bloomfield
Apr 6, 2004·Leukemia & Lymphoma·Livio PaganoGiuseppe Leone
Nov 16, 2004·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Lilia TalaricoRichard Pazdur
May 24, 2005·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Stacey L BergUNKNOWN Children's Oncology Group
May 24, 2005·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·J KurtzbergB S Mitchell
Nov 24, 2005·Hematology·Oliver G Ottmann, Barbara Wassmann

❮ Previous
Next ❯

Citations

Jul 1, 2007·Current Hematologic Malignancy Reports·Deborah A ThomasHagop Kantarjian
May 10, 2008·Annals of Oncology : Official Journal of the European Society for Medical Oncology·R ShivakumarM Wetzler
Jan 12, 2012·Current Opinion in Oncology·Samer K KhaledStephen J Forman
Mar 6, 2008·Drugs·Mark Sanford, Katherine A Lyseng-Williamson
Oct 15, 2009·Hematology/oncology Clinics of North America·Farhad Ravandi, Partow Kebriaei
Dec 17, 2015·Journal of Clinical Laboratory Analysis·Yanaphat ManthawornsiriKulachart Jangpatarapongsa
Dec 6, 2008·British Journal of Haematology·Jacob M Rowe
Oct 12, 2014·Revista brasileira de hematologia e hemoterapia·Ilana de França AzevedoRaul Antônio Morais Melo
Apr 12, 2014·Frontiers in Oncology·Kathrin M Bernt, Stephen P Hunger
May 29, 2016·Chinese Journal of Cancer·Zhi-Jie KangQuentin Liu
Jun 2, 2016·Therapeutic Advances in Hematology·Jonathan E Benjamin, Anthony S Stein
Oct 3, 2018·Leukemia & Lymphoma·Kevin C MillerHassan B Alkhateeb
Sep 1, 2009·Yonsei Medical Journal·Patrick Tan

❮ Previous
Next ❯

Related Concepts

Related Feeds

Blood And Marrow Transplantation

The use of hematopoietic stem cell transplantation or blood and marrow transplantation (bmt) is on the increase worldwide. BMT is used to replace damaged or destroyed bone marrow with healthy bone marrow stem cells. Here is the latest research on bone and marrow transplantation.